| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038603A1 Phosphate ion adsorbent |
| 04/13/2006 | WO2006037449A2 Iron complex for use in the treatment and/or prevention of nutritional disorders |
| 04/13/2006 | WO2005123651A8 L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF |
| 04/13/2006 | WO2005063785A3 Glucopyranosyloxy-substituted aromates, medicaments containing said compounds, the use thereof, and methods for producing the same |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079484 Antithrombotic effect |
| 04/13/2006 | US20060079464 Peritoneal dialysate containing taurine |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645282A1 Use of fibrinolytic metalloproteinases for treating blood clots |
| 04/12/2006 | EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 04/12/2006 | EP1644039A2 Compositions and methods for treating coagulation related disorders |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1385858B1 Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1294394B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR |
| 04/12/2006 | EP1233767B1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1757727A Gene clone of and expression Japan lamprey oral cavity gland KGD model protein possessing anti thrombotic action |
| 04/12/2006 | CN1757637A Method for purifying VE nicotinate raw material |
| 04/12/2006 | CN1250721C Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 04/12/2006 | CN1250718C Chromatography purification process of viper venom blood clotting enzyme |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250566C Chemically modified polypeptides |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250277C Medicine with anti-inflammatory, analgetic, bacteriostatic and diuretic effects |
| 04/12/2006 | CN1250256C Products as food or medicine against thrombus and cardiac and encephalic blood vessel diseases and reducing fat and their productions |
| 04/12/2006 | CN1250236C Application of cotton total flavone for preparing medicine of antithrombotic |
| 04/12/2006 | CN1250114C Health foods containing natto kinase and fermented milk products |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026334 Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/06/2006 | WO2006037043A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 04/06/2006 | WO2006036927A1 Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor |
| 04/06/2006 | WO2006036874A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 04/06/2006 | WO2006036512A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036480A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | WO2006034822A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | WO2006034789A1 Proline derivatives |
| 04/06/2006 | WO2006034769A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074080 Combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073166 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004031343A1 Medicine-technical auxiliary agent, useful to treat hemorrhoids, comprises a combination of bitter clover, king herb, liver herb, passion herb, sorrel, yarrow, plantain, chicory (all dried) and salt less lard |
| 04/06/2006 | CA2582223A1 Crystalline forms of a pyrazolo '3, 4-c pyridine factor xa inhibitor |
| 04/06/2006 | CA2582222A1 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 04/06/2006 | CA2582071A1 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581737A1 Proline derivatives |
| 04/06/2006 | CA2581732A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 04/06/2006 | CA2581580A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/06/2006 | CA2581579A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | CA2580136A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 04/06/2006 | CA2580129A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642898A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1641752A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| 04/05/2006 | EP1641451A2 Method for photodynamic inactivation of pathogens using ala |
| 04/05/2006 | EP1641421A2 Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1245564B1 Benzamidine derivatives |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | EP0710288B1 Adenoviral vectors for treatment of hemophilia |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1754886A Blood platelet reinforcing protein and application thereof |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754574A Use of immune cell for treating blood coloboma symptom and arrest of bone marrow |